Heart failure secondary to myocarditis after SARS-CoV-2 reinfection : a case report
dc.contributor.author | Riedel, Patrícia Gabriela | pt_BR |
dc.contributor.author | Sakai, Vitoria Fedrizzi | pt_BR |
dc.contributor.author | Toniasso, Sheila de Castro Cardoso | pt_BR |
dc.contributor.author | Brum, Maria Carlota Borba | pt_BR |
dc.contributor.author | Fernandes, Fernando Schmidt | pt_BR |
dc.contributor.author | Pereira, Robson Martins | pt_BR |
dc.contributor.author | Baldin, Camila Pereira | pt_BR |
dc.contributor.author | Baldin, Cícero de Campos | pt_BR |
dc.contributor.author | Takahasi, Anderson Yudi | pt_BR |
dc.contributor.author | Shiki, Hugo | pt_BR |
dc.contributor.author | Krepsky, Ana Maria Rocha | pt_BR |
dc.contributor.author | Trindade, Damasio Macedo | pt_BR |
dc.contributor.author | Merlo, Alvaro Roberto Crespo | pt_BR |
dc.contributor.author | Rohde, Luis Eduardo Paim | pt_BR |
dc.contributor.author | Joveleviths, Dvora | pt_BR |
dc.date.accessioned | 2022-08-19T04:44:59Z | pt_BR |
dc.date.issued | 2021 | pt_BR |
dc.identifier.issn | 1878-3511 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/10183/247403 | pt_BR |
dc.description.abstract | Introduction: Cardiac involvement in COVID-19 can range from mild damage to severe myocarditis. The precise mechanism by which COVID-19 causes myocardial injury is still unknown. Myocarditis following administration of COVID-19 vaccines, especially those based on mRNA, has also been described. How- ever, no reports of heart failure following reinfection with SARS-CoV-2 in patients immunized with an inactivated vaccine have been identified. Case description: The patient was a 47-year-old male construction worker of African descent, with type II diabetes and a history of infection by SARS-CoV-2 in December 2020 and May 2021, confirmed by RT-PCR. He received two doses of an inactivated vaccine against COVID-19. Between the two COVID-19 episodes with positive RT-PCR, he had two episodes of bacterial lung infection. After the second episode of SARS-CoV-2 infection, he was diagnosed with severe heart failure as a sequela of myocarditis. Conclusion: It is essential to perform a thorough follow-up after infection with SARS-CoV-2 since, even with proper immunization, it is possible that the patient was reinfected and suffered severe cardiac se- quelae as a consequence. The hypothesis of an etiology associated with the use of an inactivated vaccine against COVID-19, with a potential immune enhancement mechanism following reinfection with SARS-CoV-2, cannot be rejected. | en |
dc.format.mimetype | application/pdf | pt_BR |
dc.language.iso | eng | pt_BR |
dc.relation.ispartof | International journal of infectious diseases. Hamilton, ON. Vol 113 (Dec. 2021), p. 175–177 | pt_BR |
dc.rights | Open Access | en |
dc.subject | Myocarditis | en |
dc.subject | COVID-19 | pt_BR |
dc.subject | SARS-CoV-2 | pt_BR |
dc.subject | Heart failure | en |
dc.subject | Miocardite | pt_BR |
dc.subject | Vaccine | en |
dc.subject | Insuficiência cardíaca | pt_BR |
dc.subject | Vacinas | pt_BR |
dc.title | Heart failure secondary to myocarditis after SARS-CoV-2 reinfection : a case report | pt_BR |
dc.type | Artigo de periódico | pt_BR |
dc.identifier.nrb | 001147099 | pt_BR |
dc.type.origin | Estrangeiro | pt_BR |
Files in this item
This item is licensed under a Creative Commons License
-
Journal Articles (40175)Health Sciences (10740)